BACKGROUND: A wide spectrum of human papillomavirus (HPV) types can infect the male
genitalia. An HPV vaccine covering HPV6 and 11 is now available. Detailed data on the …

Abstract The quadrivalent HPV types 6, 11, 16, 18 vaccine (Gardasil®) is a recombinant
vaccine comprising purified virus-like particles derived from the L1 capsid proteins of HPV …

Infection with genital human papillomavirus (HPV) types is ubiquitous, affecting 20% to 50%
people aged 15 to 25 years, 41 with a lifetime acquisition rate in the order of 60% to 80%. 34 …

It has been clearly established that sexually transmitted human papillomavirus (HPV)
infections are the major cause of genital warts and cervical cancer and are a contributing …

Overt warts must be properly managed and cured, whenever possible. Genital warts have a
cosmetic and psychosexual significance. Patients experience them as distasteful and …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …

Genital warts are manifestations of a common viral sexually transmitted disease (STD) that
are often diagnosed and treated with a variety of clinical specialties. Unlike for other STDs …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to
give protection against genital warts (GW) as well as cervical cancer. Our main question was …

Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …